· · · · · 

The FDA Needs an Action Plan for More Inclusive Clinical Trials

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

· · · · ·